Bimolecular fluorescence complementation based on the red fluorescent protein FusionRed
- 作者: Kost L.A.1,2, Putintseva E.V.1, Pereverzeva A.R.1, Chudakov D.M.1,2, Lukyanov K.A.1,3, Bogdanov A.M.1,3
-
隶属关系:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
- Pirogov Russian National Research Medical University
- Nizhny Novgorod State Medical Academy
- 期: 卷 42, 编号 6 (2016)
- 页面: 619-623
- 栏目: Article
- URL: https://bakhtiniada.ru/1068-1620/article/view/228185
- DOI: https://doi.org/10.1134/S1068162016060054
- ID: 228185
如何引用文章
详细
The aim of this work is to construct split variants of the red fluorescent protein FusionRed, each of which consists of two separate polypeptides, nonfluorescent parts of FusionRed, that can form functional fluorescent proteins upon reassociation. At the first stage, various circularly permuted FusionRed variants have been created (in circular permutants the protein polypeptide chain is divided into two parts, which change places so that the C-terminal part is followed by the N-terminal part). Two variants with the highest rate of chromophore maturation (fluorescence development) have been selected out of 23 tested permutation points. These proteins called cpFR76-73 and cpFR189-188 (the first number indicates the last amino acid residue of the N-terminal part; the second number, the first residue of the C-terminal part) are spectrally similar to parental FusionRed but possess lower fluorescence quantum yields. Split variants corresponding to these two circular permutants have been tested in mammalian cells. For reassembly of the fluorescent protein fragments, heterodimerizing leucine zippers have been used. It has been shown that split variant FR189-188 matures at 37°C and possesses fluorescence brightness similar to that of FusionRed. Consequently, FR189-188 is potentially suitable for a wide range of applications, for example, the study of protein–protein interactions or visualization of cell populations, in which two target gene promoters are simultaneously active.
作者简介
L. Kost
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pirogov Russian National Research Medical University
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997; Moscow, 117997
E. Putintseva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997
A. Pereverzeva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997
D. Chudakov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pirogov Russian National Research Medical University
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997; Moscow, 117997
K. Lukyanov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Nizhny Novgorod State Medical Academy
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997; Nizhny Novgorod, 603005
A. Bogdanov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Nizhny Novgorod State Medical Academy
编辑信件的主要联系方式.
Email: noobis@yandex.ru
俄罗斯联邦, Moscow, 117997; Nizhny Novgorod, 603005
补充文件
